Literature DB >> 10943634

Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.

J A Wedzicha1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10943634      PMCID： PMC1765946          DOI： 10.1136/thorax.55.suppl_1.s23

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  26 in total

1.  British Thoracic Society winter meeting. London, United Kingdom, 13-15 December 1999. Abstracts.

Authors: 
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

2.  Intravenous and oral corticosteroids for the prevention of relapse after treatment of decompensated COPD. Effect on patients with a history of multiple relapses.

Authors:  G H Murata; M S Gorby; T W Chick; A K Halperin
Journal:  Chest       Date:  1990-10       Impact factor: 9.410

3.  Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects.

Authors:  D J Fraenkel; P G Bardin; G Sanderson; F Lampe; S L Johnston; S T Holgate
Journal:  Am J Respir Crit Care Med       Date:  1995-03       Impact factor: 21.405

4.  Airway eosinophilia in chronic bronchitis during exacerbations.

Authors:  M Saetta; A Di Stefano; P Maestrelli; G Turato; M P Ruggieri; A Roggeri; P Calcagni; C E Mapp; A Ciaccia; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  1994-12       Impact factor: 21.405

5.  Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.

Authors:  S V Culpitt; W Maziak; S Loukidis; J A Nightingale; J L Matthews; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  [Infectious agents associated with exacerbations of chronic obstructive bronchopneumopathies and asthma attacks].

Authors:  F Philit; J Etienne; A Calvet; J F Mornex; V Trillet; M Aymard; J Brune; J F Cordier
Journal:  Rev Mal Respir       Date:  1992       Impact factor: 0.622

7.  Role of infection in chronic bronchitis.

Authors:  D W Gump; C A Phillips; B R Forsyth; K McIntosh; K R Lamborn; W H Stouch
Journal:  Am Rev Respir Dis       Date:  1976-04

8.  Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

Authors:  R Zalacain; V Sobradillo; J Amilibia; J Barrón; V Achótegui; J I Pijoan; J L Llorente
Journal:  Eur Respir J       Date:  1999-02       Impact factor: 16.671

9.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.

Authors:  S L Johnston; P K Pattemore; G Sanderson; S Smith; F Lampe; L Josephs; P Symington; S O'Toole; S H Myint; D A Tyrrell
Journal:  BMJ       Date:  1995-05-13

10.  Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis.

Authors:  C M Callahan; R S Dittus; B P Katz
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391
View more
  3 in total

Review 1.  Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.

Authors:  Maria Tsoumakidou; Nikolaos M Siafakas
Journal:  Respir Res       Date:  2006-05-22

2.  Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?

Authors:  Hasse Melbye; Salwan Al-Ani; Mark Spigt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-08

Review 3.  Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.

Authors:  Julia Ae Walters; Daniel J Tan; Clinton J White; Richard Wood-Baker
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.